U.S. Banks Stock News

Calix (NYSE:CALX) has filed a definitive proxy statement urging shareholders to vote against a proposal to change voting requirements in its charter and bylaws. The board’s opposition creates a clear divide between management and certain shareholders on corporate governance ahead of the upcoming annual meeting. The proposal focuses on how key decisions are approved, which may affect how much influence shareholders hold over future company policies. Calix, trading at $48.78, has seen mixed...

If you are wondering whether Ball is priced fairly or if the current share price leaves some room on the table, this breakdown will help you weigh what you are really paying for. Ball shares most recently closed at US$59.26, with returns of 0.3% over 7 days, a 5.2% decline over 30 days, 11.1% year to date, 33.8% over 1 year, 18.0% over 3 years, and a 30.4% decline over 5 years. Recent headlines have focused on Ball's position in the packaging industry and its portfolio of aluminum packaging...

Kodiak AI completed its first autonomous trucking demonstration in Ohio, extending operations beyond its core Sunbelt routes into Midwest freight corridors. The company engaged with Ohio regulators and freight partners as part of the program, highlighting progress in real world deployment of its driverless technology. ARK Autonomous Tech & Robotics ETF added Kodiak AI to its holdings, indicating increased attention from a high profile thematic investor. Kodiak AI, traded as NasdaqGM:KDK, is...

Regulatory crackdown puts Qfin Holdings (NasdaqGS:QFIN) under pressure China’s latest fintech lending crackdown, including a 24% cap on borrowing costs and stricter fee disclosure rules, is pressuring Qfin Holdings (NasdaqGS:QFIN) and leading the company to rely more on its software-as-a-service offering for banks. See our latest analysis for Qfin Holdings. The latest regulatory clampdown comes on top of weak recent share price momentum, with a 30 day share price return of a 13.65% decline...

Wondering whether Encompass Health's share price still reflects good value after its recent run, or if most of the opportunity is already priced in. The stock last closed at US$105.67, with a 9.2% return over the past week, a 1.2% decline over the past month, a 0.7% decline year to date, and a 8.6% return over the past year, alongside longer term returns of 73.8% over three years and 73.0% over five years. Recent coverage has focused on Encompass Health in the context of the US healthcare...

If you are wondering whether MINISO Group Holding at about US$16.10 is offering value or asking too much, you are in the right place to unpack what that price could mean. The stock has slipped 0.6% over the last week and 4.8% over the last month, while still sitting on a 13.8% gain over the past year and a 17.4% decline year to date. Recent coverage has focused on how MINISO Group Holding fits into the broader Multiline Retail space and how investors are reacting to consumer trends and...

Wondering if Principal Financial Group at around US$91 a share offers good value or is getting ahead of itself? This article breaks down what the current price may be implying. The stock has returned 1.1% over the last 7 days, 1.8% year to date, and 36.0% over the past year, with a 1.3% decline across the last 30 days. This may hint that expectations and risk perceptions are still shifting. Recent coverage has focused on how investors are reassessing established insurers and paying closer...

In recent weeks, Century Communities, Inc. has expanded its footprint with new and upcoming residential communities across Texas, California, Kentucky, Arizona, Georgia, and South Carolina, offering upgraded finishes, smart home technology, and online homebuying options at a range of price points. This wave of geographically diverse launches, especially through the Century Complete brand and its fully online purchase process, highlights the builder’s emphasis on scalable growth and digital...

In March 2026, Kirby Corporation entered into an amended and restated credit agreement with JPMorgan and other lenders, extending its revolving credit facility to US$750,000,000 through March 2031 while refinancing existing debt, funding vessel equipment purchases, and supporting share repurchases. This expanded, longer-dated revolving facility, with scope to add up to an additional US$500,000,000 in commitments, gives Kirby greater balance sheet flexibility while retaining covenant limits...

If you are wondering whether Hershey at around US$206.98 is giving you fair value for your money or asking too much, this breakdown is designed to help you make sense of the price tag. The stock has seen mixed momentum, with a 0.4% decline over the last 7 days and an 8.0% decline over the last 30 days, alongside returns of 13.5% year to date, 34.1% over 1 year, a 13.2% decline over 3 years, and 47.0% over 5 years. Recent coverage has focused on Hershey's share price performance, with...

Institutional investors have increased exposure to Kaiser Aluminum, with new positions recently added. Allspring Global Investments Holdings LLC has acquired a substantial stake, pointing to growing interest from large funds. The company, traded as NasdaqGS:KALU, continues to attract attention as institutional ownership rises. Kaiser Aluminum, listed as NasdaqGS:KALU, is drawing fresh focus as major institutions commit more capital to the stock. The company’s recent share price of $131.98...

Wondering if DuPont de Nemours is still reasonably priced after a strong run, or if the easy gains are behind it? This article walks through the numbers so you can judge the value case for yourself. At a last close of US$45.53, the stock has posted a 0.6% move over the past month, 11.4% year to date, and 101.5% over the past year. A 0.6% decline over the last 7 days may hint that expectations and risk perceptions are shifting. Recent headlines have focused on DuPont de Nemours as a materials...

If you are wondering whether Danaher at around US$191 a share represents fair value or a potential gap you can take advantage of, this article walks through what the numbers indicate about the stock today. The share price has returned 10.1% over the past year, even though the year-to-date return shows a 17.1% decline, which can change how investors view both its potential and its risks. Recent news coverage has focused less on short-term headlines and more on keeping Danaher on the radar for...

Investors may be wondering if Zoetis at around US$116.80 is starting to look interesting again, or if the market is still pricing in too much optimism. The share price has been under pressure, with returns of 1.2% over 7 days, 3.8% over 30 days, 7.2% year to date and 17.9% over the last year, which can change how investors think about both upside and risk. Recent coverage has focused on Zoetis as a major player in animal health and on how sentiment around pharmaceutical and biotech stocks...

If you are looking at FMC and wondering whether the current share price reflects its true worth, the valuation picture is the key question to focus on next. The stock last closed at US$17.64, with returns of 2.4% over 7 days, 25.6% over 30 days and 23.0% year to date. This is set against a 45.9% decline over 1 year, an 83.5% decline over 3 years and an 81.4% decline over 5 years. Recent attention on FMC has centered on how these mixed returns fit with the broader chemicals sector and shifts...

ResMed (NYSE:RMD) has seen continued insider selling by a key executive, with no insider purchases reported over the past year. The pattern of selling without offsetting buying activity is drawing attention as a governance and sentiment signal for shareholders. The company’s shares most recently closed at $226.05. For investors tracking ResMed, the insider activity comes alongside a mixed share price record. The stock is at $226.05, with a 1-year return of 11.5% and a 5-year return of...

Loews (L) is back in focus after key subsidiary CNA Financial announced a 4% increase to its regular dividend and a special dividend, yet recent trading reflects broader caution toward financial stocks. See our latest analysis for Loews. Despite caution around financial stocks, Loews’ recent trading tells a more resilient story, with a 90-day share price return of 2.34% and a 1-year total shareholder return of 32.83% that reflects momentum built over a longer period. If this kind of steady...

QXO (QXO), a distributor of roofing and building products across the United States and Canada, has been drawing attention after a period of mixed share performance and ongoing questions about how its current valuation lines up with fundamentals. See our latest analysis for QXO. Recent trading has been weak, with a 30-day share price return of negative 13.67% and a 90-day share price return of negative 19.50%. However, the 1-year total shareholder return is 52.39%, which suggests that while...

If you are wondering whether Apple Hospitality REIT is attractively priced or not, a good starting point is to look at how its current share price lines up with different measures of value. The stock recently closed at US$11.63, with a 1% gain over the last week, a 4.2% decline over the last month, a 3.6% decline year to date, and an 18.2% return over the last year. These figures give you mixed signals about both risk and opportunity. Recent news coverage has focused on Apple Hospitality...

Madrigal Pharmaceuticals overview Madrigal Pharmaceuticals (MDGL) has been drawing closer attention after recent trading, with the stock closing at US$511.89 and showing mixed return patterns over the past year and past 3 months. See our latest analysis for Madrigal Pharmaceuticals. The 18.27% 1 month share price return contrasts with a 13.80% share price decline year to date. The 1 year total shareholder return of 69.06% points to stronger longer term momentum. If you are weighing Madrigal...

Over the last 7 days, the United States market has risen by 1.2%, contributing to a remarkable 33% increase over the past year, with earnings forecasted to grow by 16% annually. In this thriving environment, growth stocks with high insider ownership often signal strong confidence from those closest to the company, making them worth considering for their potential alignment with current market trends.

The market has climbed 1.2% in the last 7 days and is up 33% over the last 12 months, with earnings forecast to grow by 16% annually. Investing in penny stocks can still open doors to growth opportunities, typically in smaller or newer companies that come backed by strong financial health. Let's explore several penny stocks that could pair balance sheet strength with long-term potential.

The United States market has shown impressive momentum, climbing 1.2% in the last week and rising 33% over the past year, with earnings projected to grow by 16% annually. In such a dynamic environment, identifying stocks that offer unique value propositions and growth potential can be key to uncovering hidden opportunities.

The United States market has experienced a 1.2% increase over the last week and a notable 33% rise over the past year, with earnings projected to grow by 16% annually. In this thriving environment, identifying strong dividend stocks can be crucial for investors seeking both income and potential growth, as they offer regular payouts while potentially benefiting from overall market gains.